US Patent 7151200 Histamine receptor H3 modified transgenic mice
Patent 7151200 was granted and assigned to Ortho-McNeil Pharmaceutical on December, 2006 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7151200 Histamine receptor H3 modified transgenic mice
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.